Capricor Therapeutics (CAPR) Receivables - Other (2016 - 2025)
Capricor Therapeutics (CAPR) has 13 years of Receivables - Other data on record, last reported at $59167.0 in Q3 2025.
- For Q3 2025, Receivables - Other fell 85.56% year-over-year to $59167.0; the TTM value through Sep 2025 reached $59167.0, down 85.56%, while the annual FY2024 figure was $10.4 million, 0.03% changed from the prior year.
- Receivables - Other reached $59167.0 in Q3 2025 per CAPR's latest filing, down from $59509.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $10.4 million in Q4 2023 and bottomed at $59167.0 in Q3 2025.
- Average Receivables - Other over 5 years is $1.4 million, with a median of $409682.0 recorded in 2024.
- Peak YoY movement for Receivables - Other: soared 1794.15% in 2023, then crashed 85.56% in 2025.
- A 5-year view of Receivables - Other shows it stood at $391750.0 in 2021, then soared by 39.78% to $547580.0 in 2022, then skyrocketed by 1794.15% to $10.4 million in 2023, then dropped by 0.03% to $10.4 million in 2024, then plummeted by 99.43% to $59167.0 in 2025.
- Per Business Quant database, its latest 3 readings for Receivables - Other were $59167.0 in Q3 2025, $59509.0 in Q2 2025, and $59834.0 in Q1 2025.